Thursday, July 31, 2025 9:00:57 AM
i think this is back over $1 today.
they are very cash heavy with no near term need to raise anymore funds.
$50 million in cash.
and now a partnership or a joint venture or even a possible buy out in the cards.
and they are getting ready for phase 3.
large portfolio of drugs and $50 million in cash.
now add the top line results for their lead drug.
this is massively undervalued.
they are very cash heavy with no near term need to raise anymore funds.
$50 million in cash.
and now a partnership or a joint venture or even a possible buy out in the cards.
and they are getting ready for phase 3.
large portfolio of drugs and $50 million in cash.
now add the top line results for their lead drug.
this is massively undervalued.
Recent IXHL News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2026 01:29:02 PM
- Incannex Healthcare Officially Commences DReAMzz Clinical Study for IHL-42X in Obstructive Sleep Apnea • GlobeNewswire Inc. • 05/14/2026 02:35:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2026 11:30:31 AM
- Incannex Healthcare Wins MedTech Breakthrough Award for IHL-42X, Underscoring Leadership in Next-Generation Drug Development • GlobeNewswire Inc. • 05/12/2026 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/12/2026 11:30:21 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/22/2026 12:00:44 PM
- Incannex Healthcare PSX-001 Program Aligns with White House Executive Order Accelerating Access to Psychedelic Treatments for Serious Mental Illness • GlobeNewswire Inc. • 04/22/2026 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/27/2026 12:00:23 PM
- Incannex Reactivates Share Repurchase Program, Underscoring Confidence in Valuation and Strategic Position • GlobeNewswire Inc. • 03/27/2026 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/25/2026 12:00:06 PM
- Incannex Healthcare Announces Partnership with the AASM Foundation in Support of Sleep Apnea Research • GlobeNewswire Inc. • 03/25/2026 12:00:00 PM
- Incannex says it holds $75 million in cash with zero debt after financing • IH Market News • 03/18/2026 02:24:59 PM
- Incannex Highlights Strong Balance Sheet with Approximately $75 Million in Cash and No Debt as Company Advances IHL-42X Development • GlobeNewswire Inc. • 03/18/2026 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/17/2026 12:00:21 PM
- Incannex Regains Compliance with Nasdaq Minimum Bid Price Requirement • GlobeNewswire Inc. • 03/17/2026 12:00:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 03/12/2026 08:17:41 PM
- Incannex outlines dose-optimization study for sleep apnea treatment • IH Market News • 03/12/2026 03:42:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/12/2026 12:05:33 PM
- Incannex Healthcare Inc. Announces Pricing of $10 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules • GlobeNewswire Inc. • 03/12/2026 12:05:00 PM
- Incannex Strengthens Clinical Development Pathway for IHL-42X Following Positive Phase 2 Outcomes • GlobeNewswire Inc. • 03/12/2026 12:00:00 PM
- Incannex approves 1-for-30 reverse stock split to regain Nasdaq compliance • IH Market News • 02/25/2026 03:26:23 PM
- Incannex Announces Reverse Stock Split • GlobeNewswire Inc. • 02/25/2026 02:20:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/25/2026 01:00:33 PM
- Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) 2Q 2026 • Newsfile • 02/18/2026 11:35:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/13/2026 12:48:45 PM
